Kerstin Valinder-Strinnholm

Kerstin Valinder-Strinnholm currently works at Immedica Pharma AB, as Director from 2020, KVS Invest AB, as Director, Cavastor AB, as Director, and Pollux Pharma AB, as Deputy Director.
Ms. Valinder-Strinnholm also formerly worked at Moberg Pharma AB, as Chairman from 2022 to 2025, KLIFO A, as Director, Bioservo Technologies AB, as Independent Director from 2021 to 2023, Promore Pharma AB, as Independent Director, Mendus AB, as Independent Director from 2016 to 2020, Corline Biomedical AB, as Independent Non-Executive Director, Gedea Biotech AB, as Director, Camurus AB, as Independent Director from 2015 to 2024, AstraZeneca PLC, as Principal, Astra AB, as Principal, Takeda A, as Executive Vice President-Business Development, Takeda Pharmaceuticals International AG, as Executive Vice President-Business Development, and Nycomed AB, as Executive Vice President-Business Development.
Ms. Valinder-Strinnholm received her undergraduate degree from the University of Gothenburg.